Skip to main content
← All trials
Heart FailureHeart and circulationDrugPhase 3

What this study is

Finerenone will be compared to placebo to determine efficacy and safety of treatment in patients hospitalized with acute decompensated heart failure (HF) and mildly reduced or preserved left ventricular ejection fraction.

What's being tested

  • Finerenone

    Intervention · DRUG

    Oral finerenone

  • Placebo

    Intervention · DRUG

    Matching oral placebo

Study details

Official title
Randomized Trial to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Heart Failure Patients With Left Ventricular Ejection Fraction Greater Than or Equal to 40% Hospitalized Due to an Episode of Acute Decompensated Heart Failure (REDEFINE-HF)
Sponsor
Colorado Prevention Center
Conditions
Heart Failure · Acute Heart Failure
Enrolling
5,200 people
Starts
2024-01-17
Est. completion
2027-12
Design
Quadruple-blind, randomized, parallel groups, Phase 3
Record
View on ClinicalTrials.gov ↗